These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27557349)
21. The Mind Bending Quest for Cognitive Enhancers. Arce E; Ehlers MD Clin Pharmacol Ther; 2017 Feb; 101(2):179-181. PubMed ID: 27706806 [TBL] [Abstract][Full Text] [Related]
22. How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine. Roberts CA; Jones A; Sumnall H; Gage SH; Montgomery C Eur Neuropsychopharmacol; 2020 Sep; 38():40-62. PubMed ID: 32709551 [TBL] [Abstract][Full Text] [Related]
23. Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Brady KT; Gray KM; Tolliver BK Pharmacol Biochem Behav; 2011 Aug; 99(2):285-94. PubMed ID: 21557964 [TBL] [Abstract][Full Text] [Related]
24. A review of the effects of modafinil on cognition in schizophrenia. Morein-Zamir S; Turner DC; Sahakian BJ Schizophr Bull; 2007 Nov; 33(6):1298-306. PubMed ID: 17634412 [TBL] [Abstract][Full Text] [Related]
26. Drugs for cognitive loss and dementia. Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667 [No Abstract] [Full Text] [Related]
27. Cognitive enhancers--performance or problem? Sharp C Occup Med (Lond); 2016 Mar; 66(2):88-9. PubMed ID: 26892595 [No Abstract] [Full Text] [Related]
28. Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial. Goez HR; Scott O; Nevo N; Bennett-Back O; Zelnik N J Child Neurol; 2012 Dec; 27(12):1547-52. PubMed ID: 22447850 [TBL] [Abstract][Full Text] [Related]
29. The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults: The Clinical and Ethical Debates. Koren G; Korn L J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):100-102. PubMed ID: 33666399 [TBL] [Abstract][Full Text] [Related]
30. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. Battleday RM; Brem AK Eur Neuropsychopharmacol; 2015 Nov; 25(11):1865-81. PubMed ID: 26381811 [TBL] [Abstract][Full Text] [Related]
35. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. Wilens TE; Waxmonsky J; Scott M; Swezey A; Kwon A; Spencer TJ; Biederman J J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):947-55. PubMed ID: 16379515 [TBL] [Abstract][Full Text] [Related]
36. Ethical aspects of the abuse of pharmaceutical enhancements by healthy people in the context of improving cognitive functions. Tomažič T; Čelofiga AK Philos Ethics Humanit Med; 2019 Apr; 14(1):7. PubMed ID: 31023334 [TBL] [Abstract][Full Text] [Related]
37. Gin and juice: modafinil tightens up the drinker's brain at rest. Minzenberg MJ Biol Psychiatry; 2013 Apr; 73(8):704-5. PubMed ID: 23540352 [No Abstract] [Full Text] [Related]
38. Cognition enhancers between treating and doping the mind. Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672 [TBL] [Abstract][Full Text] [Related]
40. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Amiri S; Mohammadi MR; Mohammadi M; Nouroozinejad GH; Kahbazi M; Akhondzadeh S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):145-9. PubMed ID: 17765380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]